Secondly, checking reported side effects (or the lack thereof) provides insight into safety and tolerance. ProstaVive is ...

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of viral respiratory infections, announces today that it has appointed Kenny ...

MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with ...

Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the ...

DrEO Clinic has been recognized as the best hair transplant clinic in Mexico for 2025, reinforcing its position at the ...

Manufactured in GMP-compliant facilities, Arialief also earns trust by avoiding exaggerated claims, instead promoting gradual ...

Arialief works by addressing the root cause behind symptoms of peripheral neuropathy and provides a comprehensive solution to ...

Insulin resistance is a metabolic condition in which the body's cells no longer respond effectively to insulin, the hormone ...

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for ...

Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech and Digital Health, today announces that it has co-led ...

Exercised options total USD 143.6 million; Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026; COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/ ...

The test enables earlier identification of patients with significant liver fibrosis, potentially improving outcomes through timely management and access to emerging therapies.